{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:15:36Z","timestamp":1791173736914,"version":"4.1.0"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":916,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1111\/bjd.12136","type":"journal-article","created":{"date-parts":[[2013,2,19]],"date-time":"2013-02-19T21:56:45Z","timestamp":1361311005000},"page":"733-738","source":"Crossref","is-referenced-by-count":21,"title":["Radiation-induced melanoma-associated leucoderma, systemic antimelanoma immunity and disease-free survival in a patient with advanced-stage melanoma: a case report and immunological analysis"],"prefix":"10.1093","volume":"168","author":[{"given":"H.E.","family":"Teulings","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.P.M.","family":"Tjin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.J.","family":"Willemsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Krebbers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.J.","family":"van Noesel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.H.","family":"Kemp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Nieuweboer-Krobotova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.P.W.","family":"van der Veen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.M.","family":"Luiten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2013,2,27]]},"reference":[{"key":"10.1111\/bjd.12136-BIB1|cit1","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1038\/sj.jid.5700545","article-title":"Enhanced survival associated with vitiligo expression during maintenance biotherapy for metastatic melanoma","volume":"126","author":"Boasberg","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.12136-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1001\/archderm.1987.01660320095019","article-title":"Prognostic significance of hypopigmentation in malignant melanoma","volume":"123","author":"Bystryn","year":"1987","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.12136-BIB3|cit3","doi-asserted-by":"crossref","first-page":"6681","DOI":"10.1158\/1078-0432.CCR-07-0187","article-title":"Prognostic factors related to clinical response in patients with metastatic melanoma treated by CTL-associated antigen-4 blockade","volume":"13","author":"Downey","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1111\/bjd.12136-BIB4|cit4","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2230.1991.tb00383.x","article-title":"Prolonged survival in metastatic malignant melanoma associated with vitiligo","volume":"16","author":"Duhra","year":"1991","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/bjd.12136-BIB5|cit5","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/annonc\/mdp325","article-title":"Vitiligo is an independent favourable prognostic factor in stage III and IV metastatic melanoma patients: results from a single-institution hospital-based observational cohort study","volume":"21","author":"Quaglino","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1111\/bjd.12136-BIB6|cit6","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJMoa053007","article-title":"Prognostic significance of autoimmunity during treatment of melanoma with interferon","volume":"354","author":"Gogas","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1111\/bjd.12136-BIB7|cit7","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.1002\/cncr.24627","article-title":"The benefits of adjuvant radiation therapy after therapeutic lymphadenectomy for clinically advanced, high-risk, lymph node-metastatic melanoma","volume":"115","author":"Agrawal","year":"2009","journal-title":"Cancer"},{"key":"10.1111\/bjd.12136-BIB8|cit8","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S1470-2045(12)70138-9","article-title":"Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial","volume":"13","author":"Burmeister","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1111\/bjd.12136-BIB9|cit9","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/CMR.0b013e3283531335","article-title":"An innovative approach for locally advanced stage III cutaneous melanoma: radiotherapy, followed by nodal dissection","volume":"22","author":"Foote","year":"2012","journal-title":"Melanoma Res"},{"key":"10.1111\/bjd.12136-BIB10|cit10","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1038\/jid.2009.32","article-title":"Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients","volume":"129","author":"van den Boorn","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.12136-BIB11|cit11","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1046\/j.1365-2249.2002.01949.x","article-title":"Autoantibodies in vitiligo patients are not directed to the melanocyte differentiation antigen MelanA\/MART1","volume":"129","author":"Waterman","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"10.1111\/bjd.12136-BIB12|cit12","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/ncponc1183","article-title":"CTLA-4 blockade with ipilimumab induces significant clinical benefit in a female with melanoma metastases to the CNS","volume":"5","author":"Hodi","year":"2008","journal-title":"Nat Clin Pract Oncol"},{"key":"10.1111\/bjd.12136-BIB13|cit13","doi-asserted-by":"crossref","first-page":"e119","DOI":"10.1016\/j.bjps.2008.06.063","article-title":"Malignant melanoma and vitiligo: can radiotherapy shed light on the subject?","volume":"62","author":"Abood","year":"2009","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"10.1111\/bjd.12136-BIB14|cit14","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0936-6555(05)80117-7","article-title":"Vitiligo and radiotherapy: the Koebner phenomenon demonstrated in patients with vitiligo undergoing radiotherapy for carcinoma of the breast","volume":"6","author":"Levine","year":"1994","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1111\/bjd.12136-BIB15|cit15","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00066-002-0926-7","article-title":"Vitiligo at the sites of irradiation in a patient with Hodgkin\u2019s disease","volume":"178","author":"Pajonk","year":"2002","journal-title":"Strahlenther Onkol"},{"key":"10.1111\/bjd.12136-BIB16|cit16","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2165\/00128071-200708040-00008","article-title":"Vitiligo at the site of radiotherapy for nasopharyngeal carcinoma","volume":"8","author":"Polat","year":"2007","journal-title":"Am J Clin Dermatol"},{"key":"10.1111\/bjd.12136-BIB17|cit17","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1200\/JCO.2005.03.078","article-title":"Benign lesions in cancer patients: case 3. Vitiligo after radiotherapy for breast cancer in a woman with depigmentation disorder","volume":"23","author":"Weitzen","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1111\/bjd.12136-BIB18|cit18","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1080\/000155599750010166","article-title":"Vitiligo at the site of radiotherapy for malignant thymoma","volume":"79","author":"Kim","year":"1999","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/bjd.12136-BIB19|cit19","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/S0190-9622(83)70183-0","article-title":"Malignant melanoma and vitiligo-like leukoderma: an electron microscopic study","volume":"9","author":"Koh","year":"1983","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.12136-BIB20|cit20","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/j.1610-0387.2008.06755.x","article-title":"Vitiligo and melanoma-associated hypopigmentation (MAH): shared and discriminative features","volume":"6","author":"Hartmann","year":"2008","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1111\/bjd.12136-BIB21|cit21","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.ijrobp.2005.06.032","article-title":"Combining radiotherapy and immunotherapy: a revived partnership","volume":"63","author":"Demaria","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1111\/bjd.12136-BIB22|cit22","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.ijrobp.2003.09.012","article-title":"Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated","volume":"58","author":"Demaria","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1111\/bjd.12136-BIB23|cit23","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.radonc.2005.09.008","article-title":"A phase II trial of low-dose total body irradiation and subcutaneous interleukin-2 in metastatic melanoma","volume":"77","author":"Safwat","year":"2005","journal-title":"Radiother Oncol"},{"key":"10.1111\/bjd.12136-BIB24|cit24","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S0140-6736(95)90463-8","article-title":"Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma. European Society for Hyperthermic Oncology","volume":"345","author":"Overgaard","year":"1995","journal-title":"Lancet"},{"key":"10.1111\/bjd.12136-BIB25|cit25","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1056\/NEJMoa1112824","article-title":"Immunologic correlates of the abscopal effect in a patient with melanoma","volume":"366","author":"Postow","year":"2012","journal-title":"N Engl J Med"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.12136","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/bjd.12136\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T14:03:32Z","timestamp":1676383412000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/168\/4\/733\/6614290"}},"subtitle":["Radiation-induced melanoma-associated leucoderma"],"short-title":[],"issued":{"date-parts":[[2013,2,27]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"URL":"https:\/\/doi.org\/10.1111\/bjd.12136","relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2,27]]}}}